Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 8 | 21 | 0 | 13 | 543 |
| Gross Profit | 8 | 21 | N/A | 13 | 543 |
| Operating Expenses | 29,614 | 25,704 | 36,028 | 32,965 | 27,338 |
| Operating Income | -29,606 | -25,683 | -36,028 | -32,952 | -26,795 |
| Other Income | 702 | 2,135 | -1,700 | -3,177 | 117 |
| Pre-tax Income | -28,904 | -23,548 | -37,728 | -36,129 | -26,678 |
| Net Income Continuous | -28,904 | -23,548 | -37,728 | -36,129 | -26,678 |
| Net Income | $-28,904 | $-23,548 | $-37,728 | $-36,129 | $-26,678 |
| EPS Basic Total Ops | -0.58 | -0.59 | -1.03 | -1.04 | -0.78 |
| EPS Basic Continuous Ops | -0.58 | -0.57 | -1.03 | -1.04 | -0.78 |
| EPS Diluted Total Ops | -0.58 | -0.59 | -1.03 | -1.04 | -0.78 |
| EPS Diluted Continuous Ops | -0.58 | -0.57 | -1.03 | -1.03 | -0.78 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.59 | -1.00 | -0.95 | -0.78 |
| EBITDA(a) | $-29,533 | $-25,187 | $-35,535 | $-32,626 | $-26,427 |